Lupin inks licensing pact with Japan-based I#39;rom Group

Lupin inks licensing pact with Japan-based I#39;rom Group Under the terms of the agreement, I#39;rom along with the Mumbai-based drugmaker will conduct clinical trials, register, distribute and market biosimilar Denosumab in Japan on an exclusive basis.

from Moneycontrol Business News https://ift.tt/cCZW1Yl
Posted by: at
Tags:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Start-up Street: Social justice and the start-up ecosystem

Disparities in start-ups are a global phenomenon and affirmative action is needed to ensure an equal opportunities environment for aspiring...